Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Startups & Unicorns companies in Hyperlipidemia
by Most Patent Filings in the world in 2020

The Hyperlipidemia top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filings Hyperlipidemia Startups & Unicorns in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Hyperlipidemia is abnormally elevated levels of any or all lipids or lipoproteins in the blood. It is the most common form of dyslipidemia (which includes any abnormal lipid levels). Lipids (water-insoluble molecules) are transported in a protein capsule. The size of that capsule, or lipoprotein, determines its density. The lipoprotein density and type of apolipoproteins it contains determines the fate of the particle and its influence on metabolism.
#
Company Name
Region
Tech Topics
Total
1
ImmunoMet Therapeutics, Inc.
Medicine,Health care,Pharmacy and Therapeutics,
...[+2]
Patent: 17
2
NewAmsterdam Pharma BV
Noord-Holland, Netherlands
Biology
Patent: 14
3
INSERM Limoges
E-commerce
Patent: 13
4
SCOHIA PHARMA, Inc.
Kanagawa, Japan
Health care,Patiromer,Cardiovascular agent,
...[+2]
Patent: 8
5
Arkay Therapeutics LLC
Diabetes Therapy,Health care
Patent: 4
6
GI Innovation, Inc.
South Korea
Microbiome,Drug development,Biopharmaceutical,
...[+1]
Patent: 3
7
G2GBio, Inc.
South Korea
Health care
Patent: 3
8
Jiangsu Atom Bioscience & Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Drug,Health care
Patent: 2
9
Zhiyi Pharmaceutics, Inc.
Guangdong Sheng, China
Probiotic,Medicine,Drug,
...[+2]
Patent: 2
10
Shenzhen Lingzhi Medical Technology Co. Ltd.
Hunan Sheng, China
Software,Health care
Patent: 1
Page generation time: May 21 2025